Amneal Pharmaceuticals Reaps $2.5M in Kentucky Incentives
05/11/2010
"In addition to compelling economic incentives, we recognized that the superb quality and dedication of Glasgow's work force is a key factor in Amneal's reputation for service excellence, so the decision to stay and expand operations in Kentucky was an easy one," said Jim Luce, Amneal executive vice president of sales and marketing.
The Kentucky Economic Development Finance Authority has pre-approved Amneal for tax incentives up to $2.5 million through the Kentucky Business Investment program.
Amneal plans to use the funds to consolidate distribution logistics and sales in a 115,000-square-foot Glasgow facility. It will combine distribution that currently exists in Long Island, New York and Fountain Run, Kentucky. The company develops, manufactures, and distributes generic pharmaceuticals. It is the tenth largest supplier of generic drugs in the country in terms of prescriptions dispensed.
Project Announcements
Siemens Energy Plans Fort Payne, Alabama, Manufacturing Operations
02/09/2026
Preciball USA Plans Screven County, Georgia, Production Operations
02/09/2026
Mecad USA Plans Tulsa Port of Catoosa, Oklahoma, Manufacturing Campus
02/08/2026
Anduril Industries Plans Long Beach-Lakewood, California, Operations
02/08/2026
Dongwon Autopart Technology Plans Emanuel County, Georgia, Production Operations
02/07/2026
Quantum Machines Plans Chicago, Illinois, Operations
02/06/2026
Most Read
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Strategic Industries at the Crossroads: Defense, Aerospace, and Maritime Enter 2026
Q1 2026